Insights

Strong Industry Expertise NorthX Biologics has a longstanding presence in biologics manufacturing since 1992, with specialized capabilities in recombinant proteins, viral vaccines, and cell therapy, positioning them as a comprehensive partner for advanced biotherapeutic development and commercialization.

Recent Strategic Expansions The company has recently acquired a facility from Valneva and expanded its manufacturing capacity in Sweden, indicating a growth strategy aimed at increasing production capabilities and market reach, creating potential sales opportunities related to capacity and contract manufacturing services.

Collaborative Innovation Focus Recognized as a national innovation hub in Sweden and actively partnering with biotech firms like Mendus and Lipum, NorthX Biologics demonstrates a commitment to cutting-edge therapeutic development, making it a valuable partner for clients seeking advanced manufacturing and R&D collaboration.

Digital & Technology Adoption Utilizing a modern tech stack and leveraging platforms like AWS and WordPress indicates efficient operations and a customer-centric digital presence, providing opportunities for sales initiatives around technology solutions, digital marketing, and process automation.

Financial Growth Potential With estimated revenues between $1M and $10M and recent expansion activities, NorthX Biologics is positioned for growth, presenting prospects for sales in supply chain optimization, regulatory support, and customized manufacturing solutions to scale with their expanding portfolio.

NorthX Biologics Tech Stack

NorthX Biologics uses 8 technology products and services including Solna, LinkedIn Ads, Amazon Web Services, and more. Explore NorthX Biologics's tech stack below.

  • Solna
    Accounting And Finance
  • LinkedIn Ads
    Advertising
  • Amazon Web Services
    Cloud Hosting
  • cdnjs
    Content Delivery Network
  • WordPress
    Content Management System
  • oEmbed
    Dev Tools
  • jQuery Migrate
    Javascript Libraries
  • Priority Hints
    Performance

Media & News

NorthX Biologics's Email Address Formats

NorthX Biologics uses at least 1 format(s):
NorthX Biologics Email FormatsExamplePercentage
First.Last@nxbio.comJohn.Doe@nxbio.com
50%
First.Last@nxbio.comJohn.Doe@nxbio.com
50%

Frequently Asked Questions

What is NorthX Biologics's official website and social media links?

Minus sign iconPlus sign icon
NorthX Biologics's official website is nxbio.com and has social profiles on LinkedInCrunchbase.

What is NorthX Biologics's NAICS code?

Minus sign iconPlus sign icon
NorthX Biologics's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does NorthX Biologics have currently?

Minus sign iconPlus sign icon
As of January 2026, NorthX Biologics has approximately 122 employees across 3 continents, including EuropeAsiaNorth America. Key team members include Chief Executive Officer: J. H.Cfo: M. R.Chief Commercial Officer (cco): M. G.. Explore NorthX Biologics's employee directory with LeadIQ.

What industry does NorthX Biologics belong to?

Minus sign iconPlus sign icon
NorthX Biologics operates in the Pharmaceutical Manufacturing industry.

What technology does NorthX Biologics use?

Minus sign iconPlus sign icon
NorthX Biologics's tech stack includes SolnaLinkedIn AdsAmazon Web ServicescdnjsWordPressoEmbedjQuery MigratePriority Hints.

What is NorthX Biologics's email format?

Minus sign iconPlus sign icon
NorthX Biologics's email format typically follows the pattern of First.Last@nxbio.com. Find more NorthX Biologics email formats with LeadIQ.

When was NorthX Biologics founded?

Minus sign iconPlus sign icon
NorthX Biologics was founded in 2021.

NorthX Biologics

Pharmaceutical ManufacturingVästernorrland, Sweden51-200 Employees

Nestled in Sweden's life sciences heartland, NorthX Biologics has been at the forefront of biologics manufacturing and process development since 1992. Our rich heritage in Good Manufacturing Practice (GMP) is not just a testament to our enduring commitment to quality but also to the trust that the biotech community has placed in us for more than three decades.
Our expertise within bioprocessing spans a variety of advanced modalities, including recombinant proteins, viral vaccines and cell therapy, supporting projects from concept through to commercial manufacturing offering a full spectrum of GMP-compliant services. It is our relentless pursuit of excellence and innovation that led to our recognition in 2021 as a national innovation hub for advanced therapeutics and vaccines by the Swedish Government, a milestone that underscores our role in shaping the future of healthcare.
We are more than a CDMO; we are pioneers and partners in the truest sense. At NorthX Biologics, we believe in embarking on a collaborative journey with our clients, navigating the complexities of biologics and growing along the way. Let's journey together to turn visionary science into life-changing treatments.

We specialise in:
Process development
Analytical development
Recombinant proteins
Virus & Vectors
Cell Therapy
Extracellular Vesicles
Aseptic fill & finish
Microbial & mammalian production
QC, QA, QP

Section iconCompany Overview

Website
nxbio.com
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2021
Employees
51-200

Section iconFunding & Financials

  • $1M$10M

    NorthX Biologics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    NorthX Biologics's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.